DD219770A5 - Verfahren zur herstellung von piperidindion-derivaten - Google Patents

Verfahren zur herstellung von piperidindion-derivaten Download PDF

Info

Publication number
DD219770A5
DD219770A5 DD83256411A DD25641183A DD219770A5 DD 219770 A5 DD219770 A5 DD 219770A5 DD 83256411 A DD83256411 A DD 83256411A DD 25641183 A DD25641183 A DD 25641183A DD 219770 A5 DD219770 A5 DD 219770A5
Authority
DD
German Democratic Republic
Prior art keywords
formula
hydrogen
pyridyl
group
temperature
Prior art date
Application number
DD83256411A
Other languages
German (de)
English (en)
Inventor
Claude Bernhart
Werner Cautreels
Patrick Gautier
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DD219770A5 publication Critical patent/DD219770A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD83256411A 1982-11-08 1983-11-07 Verfahren zur herstellung von piperidindion-derivaten DD219770A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8218706A FR2535721A1 (fr) 1982-11-08 1982-11-08 Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives

Publications (1)

Publication Number Publication Date
DD219770A5 true DD219770A5 (de) 1985-03-13

Family

ID=9279000

Family Applications (3)

Application Number Title Priority Date Filing Date
DD83256411A DD219770A5 (de) 1982-11-08 1983-11-07 Verfahren zur herstellung von piperidindion-derivaten
DD83270121A DD229402A5 (de) 1982-11-08 1983-11-07 Verfahren zur herstellung von piperidinion-derivaten, die als myocard-schutz eine antiarrhytmische aktivitaet ausweisen
DD83270120A DD229407A5 (de) 1982-11-08 1983-11-07 Verfahren zur herstellung von piperidindion-derivaten, die als myocard-schutz eine antiarrhytmische aktivitaet aufweisen

Family Applications After (2)

Application Number Title Priority Date Filing Date
DD83270121A DD229402A5 (de) 1982-11-08 1983-11-07 Verfahren zur herstellung von piperidinion-derivaten, die als myocard-schutz eine antiarrhytmische aktivitaet ausweisen
DD83270120A DD229407A5 (de) 1982-11-08 1983-11-07 Verfahren zur herstellung von piperidindion-derivaten, die als myocard-schutz eine antiarrhytmische aktivitaet aufweisen

Country Status (29)

Country Link
US (1) US4721710A (es)
EP (1) EP0110755B1 (es)
JP (1) JPS59161377A (es)
KR (1) KR900006721B1 (es)
AT (1) ATE22561T1 (es)
AU (1) AU565519B2 (es)
CA (1) CA1221967A (es)
CS (1) CS244681B2 (es)
DD (3) DD219770A5 (es)
DE (1) DE3366623D1 (es)
DK (1) DK511383A (es)
ES (1) ES527091A0 (es)
FI (1) FI79536C (es)
FR (1) FR2535721A1 (es)
GR (1) GR78747B (es)
HU (1) HU191494B (es)
IE (1) IE56209B1 (es)
IL (1) IL70099A (es)
MA (1) MA19948A1 (es)
NO (1) NO159852C (es)
NZ (1) NZ206177A (es)
OA (1) OA07582A (es)
PH (1) PH20421A (es)
PL (3) PL139946B1 (es)
PT (1) PT77607B (es)
SG (1) SG1989G (es)
SU (3) SU1333237A3 (es)
YU (3) YU221183A (es)
ZA (1) ZA838065B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668689A (en) * 1984-07-19 1987-05-26 National Research Development Corporation Glutarimide derivatives for treating oestrogen-dependent tumors
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US9376438B2 (en) 2011-05-17 2016-06-28 Principia Biopharma, Inc. Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
SI2710005T1 (sl) 2011-05-17 2017-03-31 Principia Biopharma Inc. Zaviralci tirozinske kinaze
US9580427B2 (en) 2011-05-17 2017-02-28 The Regents Of The University Of California Kinase inhibitors
DK3181567T3 (da) 2012-09-10 2019-06-11 Principia Biopharma Inc Pyrazolopyrimidinforbindelser som kinasehæmmere
US8957080B2 (en) 2013-04-09 2015-02-17 Principia Biopharma Inc. Tyrosine kinase inhibitors
CN112353806A (zh) 2014-02-21 2021-02-12 普林斯匹亚生物制药公司 Btk抑制剂的盐和固体形式
PT3233103T (pt) 2014-12-18 2021-01-18 Principia Biopharma Inc Tratamento de pênfigo
TW201718572A (zh) 2015-06-24 2017-06-01 普林斯匹亞生物製藥公司 酪胺酸激酶抑制劑
CA3028169A1 (en) 2016-06-29 2018-01-04 Principia Biopharma Inc. Modified release formulations of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2664424A (en) * 1953-12-29 Dioxo-piperidines
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
FR2467200A1 (fr) * 1979-10-11 1981-04-17 Clin Midy Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire

Also Published As

Publication number Publication date
YU184185A (en) 1986-06-30
FI834087A0 (fi) 1983-11-08
HU191494B (en) 1987-02-27
DD229407A5 (de) 1985-11-06
FI79536B (fi) 1989-09-29
ES8406070A1 (es) 1984-07-01
NO834057L (no) 1984-05-09
IL70099A (en) 1987-10-20
NZ206177A (en) 1985-11-08
FR2535721B1 (es) 1985-05-17
SU1333238A3 (ru) 1987-08-23
GR78747B (es) 1984-10-02
DK511383D0 (da) 1983-11-08
PL244462A1 (en) 1985-02-13
PT77607A (fr) 1983-12-01
CS244681B2 (en) 1986-08-14
EP0110755B1 (fr) 1986-10-01
ES527091A0 (es) 1984-07-01
US4721710A (en) 1988-01-26
PL140021B1 (en) 1987-03-31
IE832581L (en) 1984-05-08
PH20421A (en) 1987-01-05
EP0110755A1 (fr) 1984-06-13
SG1989G (en) 1989-06-02
PL139946B1 (en) 1987-03-31
OA07582A (fr) 1985-03-31
IL70099A0 (en) 1984-01-31
JPS59161377A (ja) 1984-09-12
NO159852B (no) 1988-11-07
ATE22561T1 (de) 1986-10-15
SU1333237A3 (ru) 1987-08-23
ZA838065B (en) 1984-06-27
KR900006721B1 (ko) 1990-09-20
PL249750A1 (en) 1985-03-12
AU2089883A (en) 1984-05-17
NO159852C (no) 1989-02-15
MA19948A1 (fr) 1984-07-01
YU221183A (en) 1986-06-30
IE56209B1 (en) 1991-05-22
CA1221967A (en) 1987-05-19
FI79536C (fi) 1990-01-10
YU184285A (en) 1986-06-30
KR840006641A (ko) 1984-12-01
DE3366623D1 (en) 1986-11-06
PL249749A1 (en) 1985-03-12
DD229402A5 (de) 1985-11-06
AU565519B2 (en) 1987-09-17
DK511383A (da) 1984-05-09
FR2535721A1 (fr) 1984-05-11
PT77607B (fr) 1986-03-18
FI834087A (fi) 1984-05-09
SU1316558A3 (ru) 1987-06-07
PL140992B1 (en) 1987-06-30

Similar Documents

Publication Publication Date Title
DE1695556C3 (de) 3-Alkyl-1,2,3,4,4a,9-hexahydropyrazino[1,2-f]morphanthridinderivate
DD146600A5 (de) Verfahren zur herstellung von n hoch 2-arylsulfonyl-l-argininamiden und der pharmazeutisch annehmbaren salze
DD227963A5 (de) Verfahren zur herstellung von 1-benzyl-aminoalkyl-pyrrolidinone
DE2845499A1 (de) Alkanoylprolin-derivate und deren homologen, ihre herstellung und verwendung
DD219770A5 (de) Verfahren zur herstellung von piperidindion-derivaten
AT368130B (de) Verfahren zur herstellung von neuen 9-aminoalkyl- fluorenen und von deren salzen
DE3149010A1 (de) (+)-2-(1-(2,6-dichlorphenoxy)-ethyl)-1,3- diazacyclopent-2-en, dessen herstellung und seine verwendung in pharamazeutischen praeparaten
DE69720021T2 (de) 1,4-disubstituierte piperazine
DE68912252T2 (de) Imidazolantiarrythmische Mittel.
CH618439A5 (es)
DE69026087T2 (de) Substituierte 2-imidazoline und verfahren zur herstellung sowie deren verwendung
DE2007345A1 (de) Neue substituierte Hexahydroimidazochinoline und deren Säureanlagerungssalze
DE3723648A1 (de) Indol-derivate, ihre herstellung und sie enthaltende arzneimittel
DE2359816C2 (es)
DE69302087T2 (de) Trazodone alkyl derivate mit zns wirkung
AT391866B (de) Verfahren zur herstellung neuer s-triazolo (1,5-a) pyrimidine
DD139842A5 (de) Verfahren zur herstellung quaternaerer ammoniumsalze von phenylpropylaminen und phenylbutylaminen
DE60104866T2 (de) Aminoalkenylbenzoyl-benzofurane oder benzothiophene, verfahren zur ihrer herstellung und sie enthaltende zubereitungen
EP0126480B1 (de) Substituierte Isochinolinderivate, Verfahren zu deren Herstellung sowie Arzneimittel enthaltend diese Verbindungen
EP0266336B1 (de) Neue 1-/ 3-(2-Dialkylaminoäthoxy)-2-thienyl/-3-phenyl-1-propanone und ihre Säureadditionssalze und Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE2656227C2 (de) Basisch alkylierte Diphenyldisulfid-2,2'-biscarbonsäureamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE3040085C2 (es)
DE3813416A1 (de) 3,4-dihydroxypyrrolidin-2-on-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
DD220313A5 (de) Verfahren zur herstellung von x-butyrolacton-derivaten
CH615181A5 (en) Process for the preparation of novel ergolene derivatives

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee